Get started
KILITCH DRUGS INDIA LTDKILITCH DRUGS INDIA LTDKILITCH DRUGS INDIA LTD

KILITCH DRUGS INDIA LTD

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Seasonals

KILITCH chart


Full chart

KILITCH upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪5.07 B‬ INR
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
30.55
Basic EPS (TTM)
10.25 INR
Net income (FY)
‪146.01 M‬ INR
Revenue (FY)
‪1.54 B‬ INR
Shares float
‪4.21 M‬
Beta (1Y)
0.43

Employees


Employees (FY)
136
Change (1Y)
−29 −17.58%
Revenue / Employee (1Y)
‪136.09 K‬ INR
Net income / Employee (1Y)
‪12.87 K‬ INR

About KILITCH DRUGS INDIA LTD


Sector
Health Technology
CEO
Mukund Prataprai Mehta
Headquarters
Mumbai
Website
kilitch.com
Founded
1978
ISIN
INE729D01010
FIGI
BBG000D4WJD5
Kilitch Drugs (India) Ltd. engages in the developing, manufacturing, and marketing of pharmaceuticals, medicinal chemical, and botanical products. Its products include OSD, parenteral, nasal, opthalmic, nutritional, medical devices, and cosmetics products. The company was founded by Pratap Keshavji Mehta in 1978 and is headquartered in Mumbai, India.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

KILITCH news



Ideas



See all ideas 

Technicals

Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of KILITCH is 313.55 INR — it has increased by 0.29% in the past 24 hours. Watch KILITCH DRUGS INDIA LTD stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NSE exchange KILITCH DRUGS INDIA LTD stocks are traded under the ticker KILITCH.
KILITCH stock has risen by 2.47% compared to the previous week, the month change is a −4.74% fall, over the last year KILITCH DRUGS INDIA LTD has showed a −3.94% decrease.
KILITCH reached its all-time high on Feb 8, 2024 with the price of 470.00 INR, and its all-time low was 17.00 INR and was reached on Jun 13, 2013. View more price dynamics on KILITCH chart.
See other stocks reaching their highest and lowest prices.
KILITCH stock is 4.47% volatile and has beta coefficient of 0.43. Track KILITCH DRUGS INDIA LTD stock price on the chart and check out the list of the most volatile stocks — is KILITCH DRUGS INDIA LTD there?
Today KILITCH DRUGS INDIA LTD has the market capitalization of ‪5.07 B‬, it has decreased by −4.32% over the last week.
Yes, you can track KILITCH DRUGS INDIA LTD financials in yearly and quarterly reports right on TradingView.
KILITCH DRUGS INDIA LTD is going to release the next earnings report on Feb 18, 2025. Keep track of upcoming events with our Earnings Calendar.
KILITCH net income for the last quarter is ‪86.17 M‬ INR, while the quarter before that showed ‪13.40 M‬ INR of net income which accounts for 542.92% change. Track more KILITCH DRUGS INDIA LTD financial stats to get the full picture.
KILITCH DRUGS INDIA LTD dividend yield was 0.00% in 2023, and payout ratio reached 0.00%. The year before the numbers were 0.00% and 0.00% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Nov 20, 2024, the company has 136.00 employees. See our rating of the largest employees — is KILITCH DRUGS INDIA LTD on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. KILITCH DRUGS INDIA LTD EBITDA is ‪171.09 M‬ INR, and current EBITDA margin is 16.01%. See more stats in KILITCH DRUGS INDIA LTD financial statements.
Like other stocks, KILITCH shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade KILITCH DRUGS INDIA LTD stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So KILITCH DRUGS INDIA LTD technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating KILITCH DRUGS INDIA LTD stock shows the buy signal. See more of KILITCH DRUGS INDIA LTD technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.